Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial
Physiotherapy Research International · 2024
DOI: 10.1002/pri.2129 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Physiotherapy Research International, 2024. Verfasst von Radwa M Shalaby und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Physical Therapy, Cairo University, Giza, Egypt. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Objective
Vulvovaginal Candidiasis (VVC) is a prevalent genital infection in women of reproductive age and requires effective non‐drug therapies. Therefore, this study aimed to investigate the effect of blue light emitting diode (LED) therapy as an alternative treatment for recurrent VVC due to its proven antimicrobial properties. The safety and non‐invasiveness of LED therapy make it a promising option for sensitive tissue applications. Materials and Methods This randomized controlled trial recruited 60 women with culture‐confirmed VVC. Participants were randomly allocated to two groups. Group A (control group) received standard antifungal treatment with Gynoconazol 0.8% vaginal cream for three consecutive nights (n = 30). Group B (study group) received the same antifungal treatment plus two 60‐min sessions of blue LED therapy directed at the vagina and vulva, with the sessions separated by two days (n = 30). Candida count (via CHROMagar™ Candida) and vaginal pH (via AD110‐AD111 m) were assessed at baseline and one week after initiating treatment.
Results
Post‐treatment, group (B) demonstrated a significantly greater reduction in Candida count compared to group (A) (mean difference (MD) 8.267; 95% Confidence Interval (CI) 6.723–9.811; p = 0.0001). However, there was no statistically significant difference in vaginal pH between the groups (MD −0.03; 95% CI −0.244–0.178; p = 0.749).
Conclusion
Blue LED therapy effectively reduces Candida count in women with recurrent VVC without adversely affecting the vaginal pH, highlighting its safety and efficacy as a treatment modality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Physical Therapy, Cairo University, Giza, Egypt.
- Department of Physical Therapy for Women's Health, Cairo University, Giza, Egypt.
- Department of Gynecology and Obstetrics, Faculty of Medicine, Cairo University, Giza, Egypt.
ORCID-Profile: Radwa M Shalaby, Soheir M El-Kosery, Mahmoud M Soliman, Doaa A Osman
Zitieren
APA
Shalaby, R. M., El-Kosery, S. M., Soliman, M. M., & Osman, D. A. (2024). Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial. Physiotherapy Research International. https://doi.org/10.1002/pri.2129
Vancouver
Shalaby RM, El-Kosery SM, Soliman MM, Osman DA. Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial. Physiotherapy Research International. 2024. doi:10.1002/pri.2129
BibTeX
@article{Shalaby2024,
author = {Shalaby, Radwa M and El-Kosery, Soheir M and Soliman, Mahmoud M and Osman, Doaa A},
title = {Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial},
journal = {Physiotherapy Research International},
year = {2024},
doi = {10.1002/pri.2129}
}
EUVIMED